20-63740459-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020062.4(SLC2A4RG):c.209C>T(p.Ala70Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000228 in 1,229,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020062.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A4RG | NM_020062.4 | c.209C>T | p.Ala70Val | missense_variant | 2/8 | ENST00000266077.5 | NP_064446.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A4RG | ENST00000266077.5 | c.209C>T | p.Ala70Val | missense_variant | 2/8 | 1 | NM_020062.4 | ENSP00000266077.2 | ||
SLC2A4RG | ENST00000474248.5 | n.217C>T | non_coding_transcript_exon_variant | 1/4 | 2 | |||||
SLC2A4RG | ENST00000485897.5 | n.80C>T | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151862Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000213 AC: 23AN: 1077750Hom.: 0 Cov.: 30 AF XY: 0.0000216 AC XY: 11AN XY: 509258
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151862Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74164
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.209C>T (p.A70V) alteration is located in exon 2 (coding exon 2) of the SLC2A4RG gene. This alteration results from a C to T substitution at nucleotide position 209, causing the alanine (A) at amino acid position 70 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at